You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 1, 2024

VANCOMYCIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Vancomycin, and what generic alternatives are available?

Vancomycin is a drug marketed by Xellia Pharms Aps, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Pai Holdings Pharm, Strides Pharma, Watson Labs, Alkem Labs Ltd, Amneal, Aspiro, Avet Lifesciences, Eugia Pharma, Gland Pharma Ltd, Hainan Poly, Hainan Poly Pharm, Hikma, Hikma Pharms, Hospira, Hospira Inc, Knack, Meitheal, Mylan Labs Ltd, Pharm Assoc, Sagent Pharms, Sandoz, Sandoz Inc, Teva Pharms Usa, Zhejiang Novus Pharm, Samson Medcl, and Baxter Hlthcare. and is included in fifty-four NDAs. There are six patents protecting this drug.

This drug has forty-seven patent family members in twenty-nine countries.

The generic ingredient in VANCOMYCIN is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vancomycin

A generic version of VANCOMYCIN was approved as vancomycin hydrochloride by FRESENIUS KABI USA on March 17th, 1987.

  Sign Up

Summary for VANCOMYCIN
International Patents:47
US Patents:5
Applicants:30
NDAs:54
Raw Ingredient (Bulk) Api Vendors: 37
Clinical Trials: 423
Patent Applications: 745
Drug Prices: Drug price information for VANCOMYCIN
What excipients (inactive ingredients) are in VANCOMYCIN?VANCOMYCIN excipients list
DailyMed Link:VANCOMYCIN at DailyMed
Drug patent expirations by year for VANCOMYCIN
Drug Prices for VANCOMYCIN

See drug prices for VANCOMYCIN

Drug Sales Revenue Trends for VANCOMYCIN

See drug sales revenues for VANCOMYCIN

Recent Clinical Trials for VANCOMYCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universitätsmedizin MannheimPhase 2
German Cancer Research CenterPhase 2
Michael DillPhase 2

See all VANCOMYCIN clinical trials

Pharmacology for VANCOMYCIN

US Patents and Regulatory Information for VANCOMYCIN

VANCOMYCIN is protected by five US patents.

Patents protecting VANCOMYCIN

Glycopeptide compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS

Glycopeptide compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS

Glycopeptide compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Glycopeptide compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Glycopeptide compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 091554-001 Sep 19, 2011 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Labs Ltd VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride POWDER;INTRAVENOUS 209481-002 Jul 10, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hainan Poly VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 215821-002 Nov 18, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fresenius Kabi Usa VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 062663-003 Jun 3, 1988 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride INJECTABLE;INJECTION 091377-002 Sep 9, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Xellia Pharms Aps VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride SOLUTION;INTRAVENOUS 211962-006 May 13, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Samson Medcl VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER vancomycin hydrochloride POWDER;INTRAVENOUS 091532-001 Jan 6, 2016 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for VANCOMYCIN

See the table below for patents covering VANCOMYCIN around the world.

Country Patent Number Title Estimated Expiration
Spain 2852550 ⤷  Sign Up
South Korea 102603756 ⤷  Sign Up
China 107073072 糖肽组合物 (Glycopeptide compositions) ⤷  Sign Up
Saudi Arabia 517381446 تركيبات مضاد حيوي (ANTIBIOTIC COMPOSITIONS) ⤷  Sign Up
Mexico 2017005749 COMPOSICIONES ANTIBIÓTICAS. (GLYCOPEPTIDE COMPOSITIONS.) ⤷  Sign Up
Japan 2017533218 グリコペプチド組成物 ⤷  Sign Up
Brazil 112017009405 composições antibióticas. ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing